Ellis Wilson
Keine laufenden Positionen mehr
Profil
Ellis Wilson worked as an Executive Director of Commercial Strategy at PPD, Inc. He then worked as a Vice President of Global Clinical Operations at VistaGen Therapeutics, Inc. from 2021 to 2022.
Prior to that, he was a Vice President of Product Development at Wavodyne Therapeutics, Inc. and a Vice President of Clinical Development at NRX Pharmaceuticals, Inc. Wilson holds a graduate degree from West Chester University of Pennsylvania, an MBA from Erivan K.
Haub School of Business, and graduate and undergraduate degrees from Temple University School of Pharmacy and Philadelphia College of Pharmacy, respectively.
Ehemalige bekannte Positionen von Ellis Wilson
| Unternehmen | Position | Ende |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2022 |
Wavodyne Therapeutics, Inc.
 Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Wavodyne Therapeutics, Inc. develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuro-inflammatory processes. The firm also provides research and development services. The company was founded by Jim New and is headquartered in Rochester, NY. | Corporate Officer/Principal | - |
| PPD, INC. | Corporate Officer/Principal | - |
| NRX PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Ellis Wilson
| Erivan K. Haub School of Business | Masters Business Admin |
| Temple University School of Pharmacy | Graduate Degree |
| West Chester University of Pennsylvania | Graduate Degree |
| Philadelphia College of Pharmacy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VISTAGEN THERAPEUTICS, INC. | Health Technology |
| NRX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Wavodyne Therapeutics, Inc.
Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Wavodyne Therapeutics, Inc. develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuro-inflammatory processes. The firm also provides research and development services. The company was founded by Jim New and is headquartered in Rochester, NY. | Health Technology |
